A Single Dose of Rituximab Does Not Deplete B Cells in Secondary Lymphoid Organs but Alters Phenotype and Function

IL-21-Induced Isotype Switching to IgG and IgA by Human Naive B Cells Is Differentially Regulated by IL-4

(2014) D. T. Avery et al.   JOURNAL OF IMMUNOLOGY

Resting Human Memory B Cells Are Intrinsically Programmed for Enhanced Survival and Responsiveness to Diverse Stimuli Compared to Naive B Cells

(2014) K. L. Good et al.   JOURNAL OF IMMUNOLOGY

Mycophenolic acid counteracts B cell proliferation and plasmablast formation in patients with systemic lupus erythematosus

(2012) Sebastian Eickenberg et al.   ARTHRITIS RESEARCH & THERAPY

In Vitro Effects of Rituximab on the Proliferation, Activation and Differentiation of Human B Cells

(2011) E. G. Kamburova et al.   AMERICAN JOURNAL OF TRANSPLANTATION

The anti-CD20 antibody rituximab reduces the Th17 cell response

(2011) Frank L. van de Veerdonk et al.   ARTHRITIS AND RHEUMATISM

Immunologic effects of rituximab on the human spleen in immune thrombocytopenia

(2011) S. Audia et al.   BLOOD

B-cell immunotherapeutics

(2011) Stanley C. Jordan et al.   Current Opinion in Organ Transplantation

Loss of CD20 and Bound CD20 Antibody from Opsonized B Cells Occurs More Rapidly Because of Trogocytosis Mediated by Fc Receptor-Expressing Effector Cells Than Direct Internalization by the B Cells

(2011) P. V. Beum et al.   JOURNAL OF IMMUNOLOGY

Primary B-Cell Deficiencies Reveal a Link between Human IL-17-Producing CD4 T-Cell Homeostasis and B-Cell Differentiation

(2011) Rita R. Barbosa et al.   PLoS One

The 5-Year Outcome of ABO-Incompatible Kidney Transplantation With Rituximab Induction

(2011) Shohei Fuchinoue et al.   TRANSPLANTATION

Characterization of a rare IL-10-competent B-cell subset in humans that parallels mouse regulatory B10 cells

(2010) Y. Iwata et al.   BLOOD

Antigenic modulation limits the efficacy of anti-CD20 antibodies: implications for antibody selection

(2010) S. A. Beers et al.   BLOOD

CD19+CD24hiCD38hi B Cells Exhibit Regulatory Capacity in Healthy Individuals but Are Functionally Impaired in Systemic Lupus Erythematosus Patients

(2010) Paul A. Blair et al.   IMMUNITY

Identification of a B cell signature associated with renal transplant tolerance in humans

(2010) Kenneth A. Newell et al.   JOURNAL OF CLINICAL INVESTIGATION

Effect of Single-Dose Rituximab on Primary Glomerular Diseases

(2010) Hidekazu Sugiura et al.   NEPHRON CLINICAL PRACTICE

Use of Intravenous Immune Globulin and Rituximab for Desensitization of Highly HLA-Sensitized Patients Awaiting Kidney Transplantation

(2010) Ashley A. Vo et al.   TRANSPLANTATION

Abnormal B-cell cytokine responses a trigger of T-cell-mediated disease in MS?

(2009) Amit Bar-Or et al.   ANNALS OF NEUROLOGY

Current status on B-cell depletion therapy in autoimmune diseases other than rheumatoid arthritis

(2009) Thomas Dörner et al.   AUTOIMMUNITY REVIEWS

Intravenous immunoglobulin preparations have no direct effect on B cell proliferation and immunoglobulin production

(2009) S. Heidt et al.   CLINICAL AND EXPERIMENTAL IMMUNOLOGY

Collapse of the CD27+ B-Cell Compartment Associated with Systemic Plasmacytosis in Patients with Advanced Melanoma and Other Cancers

(2009) E. L. Carpenter et al.   CLINICAL CANCER RESEARCH

Successful eradication of acquired factor-VIII-inhibitor using single low-dose rituximab

(2009) M. Wermke et al.   HAEMATOLOGICA

B Cell Survival in Intragraft Tertiary Lymphoid Organs After Rituximab Therapy

(2009) Olivier Thaunat et al.   TRANSPLANTATION

Rituximab therapy reduces activated B cells in both the peripheral blood and bone marrow of patients with rheumatoid arthritis: depletion of memory B cells correlates with clinical response

(2009) Magda Nakou et al.   ARTHRITIS RESEARCH & THERAPY

Human CD25highFoxp3pos regulatory T cells differentiate into IL-17-producing cells

(2008) H. J. P. M. Koenen et al.   BLOOD